This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voth, D. E.
Right arrow Articles by Ballard, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voth, D. E.
Right arrow Articles by Ballard, J. D.

Next Article 

Clinical Microbiology Reviews, April 2005, p. 247-263, Vol. 18, No. 2
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.2.247-263.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Clostridium difficile Toxins: Mechanism of Action and Role in Disease

Daniel E. Voth and Jimmy D. Ballard*

Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

As the leading cause of hospital-acquired diarrhea, Clostridium difficile colonizes the large bowel of patients undergoing antibiotic therapy and produces two toxins, which cause notable disease pathologies. These two toxins, TcdA and TcdB, are encoded on a pathogenicity locus along with negative and positive regulators of their expression. Following expression and release from the bacterium, TcdA and TcdB translocate to the cytosol of target cells and inactivate small GTP-binding proteins, which include Rho, Rac, and Cdc42. Inactivation of these substrates occurs through monoglucosylation of a single reactive threonine, which lies within the effector-binding loop and coordinates a divalent cation critical to binding GTP. By glucosylating small GTPases, TcdA and TcdB cause actin condensation and cell rounding, which is followed by death of the cell. TcdA elicits effects primarily within the intestinal epithelium, while TcdB has a broader cell tropism. Important advances in the study of these toxins have been made in the past 15 years, and these are detailed in this review. The domains, subdomains, and residues of these toxins important for receptor binding and enzymatic activity have been elegantly studied and are highlighted herein. Furthermore, there have been major advances in defining the role of these toxins in modulating the inflammatory events involving the disruption of cell junctions, neuronal activation, cytokine production, and infiltration by polymorphonuclear cells. Collectively, the present review provides a comprehensive update on TcdA and TcdB's mechanism of action as well as the role of these toxins in disease.

* Corresponding author. Mailing address: University of Oklahoma Health Sciences Center, BRC-362A, 975 NE 10th St., Oklahoma City, OK 73104. Phone: (405) 271-3855. Fax: (405) 271-1334. E-mail: jimmy-ballard{at}ouhsc.edu.

Clinical Microbiology Reviews, April 2005, p. 247-263, Vol. 18, No. 2
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.2.247-263.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Janvilisri, T., Scaria, J., Thompson, A. D., Nicholson, A., Limbago, B. M., Arroyo, L. G., Songer, J. G., Grohn, Y. T., Chang, Y.-F. (2009). Microarray Identification of Clostridium difficile Core Components and Divergent Regions Associated with Host Origin. J. Bacteriol. 191: 3881-3891 [Abstract] [Full Text]  
  • Williams, O. M., Spencer, R. C. (2009). The management of Clostridium difficile infection. Br Med Bull 0: ldp021v1-ldp021 [Abstract] [Full Text]  
  • He, X., Sun, X., Wang, J., Wang, X., Zhang, Q., Tzipori, S., Feng, H. (2009). Antibody-Enhanced, Fc Gamma Receptor-Mediated Endocytosis of Clostridium difficile Toxin A. Infect. Immun. 77: 2294-2303 [Abstract] [Full Text]  
  • Ochsner, U. A., Bell, S. J., O'Leary, A. L., Hoang, T., Stone, K. C., Young, C. L., Critchley, I. A., Janjic, N. (2009). Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model. J Antimicrob Chemother 63: 964-971 [Abstract] [Full Text]  
  • Monaghan, T, Boswell, T, Mahida, Y R (2009). Recent advances in Clostridium difficile-associated disease. Postgrad. Med. J. 85: 152-162 [Abstract] [Full Text]  
  • Egerer, M., Giesemann, T., Herrmann, C., Aktories, K. (2009). Autocatalytic Processing of Clostridium difficile Toxin B: BINDING OF INOSITOL HEXAKISPHOSPHATE. J. Biol. Chem. 284: 3389-3395 [Abstract] [Full Text]  
  • Saxton, K., Baines, S. D., Freeman, J., O'Connor, R., Wilcox, M. H. (2009). Effects of Exposure of Clostridium difficile PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model. Antimicrob. Agents Chemother. 53: 412-420 [Abstract] [Full Text]  
  • Sorg, J. A., Sonenshein, A. L. (2009). Chenodeoxycholate Is an Inhibitor of Clostridium difficile Spore Germination. J. Bacteriol. 191: 1115-1117 [Abstract] [Full Text]  
  • Grewal, S., Carver, J. G., Ridley, A. J., Mardon, H. J. (2008). Implantation of the human embryo requires Rac1-dependent endometrial stromal cell migration. Proc. Natl. Acad. Sci. USA 105: 16189-16194 [Abstract] [Full Text]  
  • Mayer, M. J., Narbad, A., Gasson, M. J. (2008). Molecular Characterization of a Clostridium difficile Bacteriophage and Its Cloned Biologically Active Endolysin. J. Bacteriol. 190: 6734-6740 [Abstract] [Full Text]  
  • Dingle, T., Wee, S., Mulvey, G. L, Greco, A., Kitova, E. N, Sun, J., Lin, S., Klassen, J. S, Palcic, M. M, Ng, K. K S, Armstrong, G. D (2008). Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology 18: 698-706 [Abstract] [Full Text]  
  • Paredes-Sabja, D., Bond, C., Carman, R. J., Setlow, P., Sarker, M. R. (2008). Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD). Microbiology 154: 2241-2250 [Abstract] [Full Text]  
  • Hinkson, P. L., Dinardo, C., DeCiero, D., Klinger, J. D., Barker, R. H. Jr. (2008). Tolevamer, an Anionic Polymer, Neutralizes Toxins Produced by the BI/027 Strains of Clostridium difficile. Antimicrob. Agents Chemother. 52: 2190-2195 [Abstract] [Full Text]  
  • Giesemann, T., Egerer, M., Jank, T., Aktories, K. (2008). Processing of Clostridium difficile toxins. J Med Microbiol 57: 690-696 [Abstract] [Full Text]  
  • Wright, A., Drudy, D., Kyne, L., Brown, K., Fairweather, N. F. (2008). Immunoreactive cell wall proteins of Clostridium difficile identified by human sera. J Med Microbiol 57: 750-756 [Abstract] [Full Text]  
  • Monaghan, T, Boswell, T, Mahida, Y R (2008). Recent advances in Clostridium difficile-associated disease. Gut 57: 850-860 [Abstract] [Full Text]  
  • Casselli, T., Lynch, T., Southward, C. M., Jones, B. W., DeVinney, R. (2008). Vibrio parahaemolyticus Inhibition of Rho Family GTPase Activation Requires a Functional Chromosome I Type III Secretion System. Infect. Immun. 76: 2202-2211 [Abstract] [Full Text]  
  • Sorg, J. A., Sonenshein, A. L. (2008). Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores. J. Bacteriol. 190: 2505-2512 [Abstract] [Full Text]  
  • Yeh, C.-Y., Lin, C.-N., Chang, C.-F., Lin, C.-H., Lien, H.-T., Chen, J.-Y., Chia, J.-S. (2008). C-Terminal Repeats of Clostridium difficile Toxin A Induce Production of Chemokine and Adhesion Molecules in Endothelial Cells and Promote Migration of Leukocytes. Infect. Immun. 76: 1170-1178 [Abstract] [Full Text]  
  • Jank, T., Giesemann, T., Aktories, K. (2007). Clostridium difficile Glucosyltransferase Toxin B-essential Amino Acids for Substrate Binding. J. Biol. Chem. 282: 35222-35231 [Abstract] [Full Text]  
  • Fortier, L.-C., Moineau, S. (2007). Morphological and Genetic Diversity of Temperate Phages in Clostridium difficile. Appl. Environ. Microbiol. 73: 7358-7366 [Abstract] [Full Text]  
  • El Bekay, R., Alba, G., Reyes, M E., Chacon, P., Vega, A., Martin-Nieto, J., Jimenez, J., Ramos, E., Olivan, J., Pintado, E., Sobrino, F. (2007). Rac2 GTPase activation by angiotensin II is modulated by Ca2+/calcineurin and mitogen-activated protein kinases in human neutrophils. J Mol Endocrinol 39: 351-363 [Abstract] [Full Text]  
  • Ostrowski, S. M., Wilkinson, B. L., Golde, T. E., Landreth, G. (2007). Statins Reduce Amyloid-beta Production through Inhibition of Protein Isoprenylation. J. Biol. Chem. 282: 26832-26844 [Abstract] [Full Text]  
  • Egerer, M., Giesemann, T., Jank, T., Satchell, K. J. F., Aktories, K. (2007). Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity. J. Biol. Chem. 282: 25314-25321 [Abstract] [Full Text]  
  • Ghose, C., Kalsy, A., Sheikh, A., Rollenhagen, J., John, M., Young, J., Rollins, S. M., Qadri, F., Calderwood, S. B., Kelly, C. P., Ryan, E. T. (2007). Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice. Infect. Immun. 75: 2826-2832 [Abstract] [Full Text]  
  • Jank, T., Giesemann, T., Aktories, K. (2007). Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17: 15R-22R [Abstract] [Full Text]  
  • Huelsenbeck, J., Dreger, S., Gerhard, R., Barth, H., Just, I., Genth, H. (2007). Difference in the Cytotoxic Effects of Toxin B from Clostridium difficile Strain VPI 10463 and Toxin B from Variant Clostridium difficile Strain 1470. Infect. Immun. 75: 801-809 [Abstract] [Full Text]  
  • Kazakova, S. V., Ware, K., Baughman, B., Bilukha, O., Paradis, A., Sears, S., Thompson, A., Jensen, B., Wiggs, L., Bessette, J., Martin, J., Clukey, J., Gensheimer, K., Killgore, G., McDonald, L. C. (2006). A Hospital Outbreak of Diarrhea Due to an Emerging Epidemic Strain of Clostridium difficile. Arch Intern Med 166: 2518-2524 [Abstract] [Full Text]  
  • Babcock, G. J., Broering, T. J., Hernandez, H. J., Mandell, R. B., Donahue, K., Boatright, N., Stack, A. M., Lowy, I., Graziano, R., Molrine, D., Ambrosino, D. M., Thomas, W. D. Jr. (2006). Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile-Induced Mortality in Hamsters. Infect. Immun. 74: 6339-6347 [Abstract] [Full Text]  
  • Dalby, A. B., Frank, D. N., St. Amand, A. L., Bendele, A. M., Pace, N. R. (2006). Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota.. Appl. Environ. Microbiol. 72: 6707-6715 [Abstract] [Full Text]  
  • Teichert, M., Tatge, H., Schoentaube, J., Just, I., Gerhard, R. (2006). Application of Mutated Clostridium difficile Toxin A for Determination of Glucosyltransferase-Dependent Effects.. Infect. Immun. 74: 6006-6010 [Abstract] [Full Text]  
  • Hamm, E. E., Voth, D. E., Ballard, J. D. (2006). Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication. Proc. Natl. Acad. Sci. USA 103: 14176-14181 [Abstract] [Full Text]  
  • Govind, R., Vediyappan, G., Rolfe, R. D., Fralick, J. A. (2006). Evidence that Clostridium difficile TcdC Is a Membrane-Associated Protein.. J. Bacteriol. 188: 3716-3720 [Abstract] [Full Text]  
  • Giesemann, T., Jank, T., Gerhard, R., Maier, E., Just, I., Benz, R., Aktories, K. (2006). Cholesterol-dependent Pore Formation of Clostridium difficile Toxin A. J. Biol. Chem. 281: 10808-10815 [Abstract] [Full Text]  
  • Ho, J. G. S., Greco, A., Rupnik, M., Ng, K. K.-S. (2005). Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl. Acad. Sci. USA 102: 18373-18378 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»